What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.

Episode metadata supplied by the publisher feed · Published Oct 9, 2023

Embed this episode

Attribution link and audio player

Ready to play

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

0:00 47:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Hematologic Oncology Update?

This episode is 47 minutes long.

When was this Hematologic Oncology Update episode published?

This episode was published on October 9, 2023.

Can I download this Hematologic Oncology Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!